PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
16603638-0	2006	Regulation of class II beta-tubulin expression by tumor suppressor p53 protein in mouse melanoma cells in response to Vinca alkaloid.	Vinca Alkaloids	118-132	transformation related protein 53, pseudogene	Mus musculus	67-70	
16603638-2	2006	We found that Vinca alkaloid enhanced expression of class II beta-tubulin isotype (mTUBB2) in mouse B16F10 melanoma cells via alteration of the tumor suppressor p53 protein.	Vinca Alkaloids	14-28	transformation related protein 53, pseudogene	Mus musculus	161-164	
9569030-0	1998	The role of MAP4 expression in the sensitivity to paclitaxel and resistance to vinca alkaloids in p53 mutant cells.	Vinca Alkaloids	79-94	transformation related protein 53, pseudogene	Mus musculus	98-101	
9569030-2	1998	Whereas many drugs, including the vinca alkaloids, often become less effective when p53 is transcriptionally inactivated, several, most notably paclitaxel, may become more effective.	Vinca Alkaloids	34-49	transformation related protein 53, pseudogene	Mus musculus	84-87	
9569030-3	1998	In studying the underlying mechanism(s), we found that increased MAP4 expression, which occurs with transcriptionally silent p53, is associated with increased sensitivity to paclitaxel and decreased sensitivity to vinca alkaloids.	Vinca Alkaloids	214-229	transformation related protein 53, pseudogene	Mus musculus	125-128